Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
N
389650
vs
K
KOSPI 200
Over the past 12 months, NextBioMedical Co Ltd has underperformed KOSPI 200, delivering a return of -53% compared to KOSPI 200's +116% growth.
Stocks Performance
389650 vs KOSPI 200
Performance Gap
389650 vs KOSPI 200
Performance By Year
389650 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
NextBioMedical Co Ltd
Glance View
NextBioMedical Co Ltd makes medical devices and biomaterial-based products used in healthcare settings. Its products are sold to hospitals, clinics, and medical distributors, where they are used in procedures, treatment, and patient recovery. The company earns money mainly by selling these regulated products and, in some cases, by supplying them through distribution or manufacturing agreements. The company sits in the part of healthcare that turns biomaterials into practical items doctors can use. That makes its business different from a drug company: it is tied more to product design, manufacturing quality, and regulatory approval than to long research cycles for new medicines. Demand comes from medical use cases rather than consumer demand. For investors, the key idea is that NextBioMedical is a product company inside the healthcare supply chain. It sells into a market where trust, safety, and repeat use matter, and where hospitals and medical partners are the main buyers.